Rodrigo Assad-Luppino
Ribeirao Preto, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: November 29, 2022
Diagnostic Agreement Among General Practitioners, Residents, and Senior Rheumatologists for Rheumatic Diseases.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: June 06, 2022
COVID-19 bimodal clinical and pathological phenotypes.
Journal: Clinical and translational medicine
Published: September 13, 2021
SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients.
SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients.
Journal: Journal of molecular cell biology
Published: June 18, 2021
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.
Journal: RMD open
Published: September 18, 2020
Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients.
Journal: The Journal of experimental medicine
Published: August 09, 2020
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.
Journal: The Journal of experimental medicine
Published: June 06, 2020
Machine learning techniques for computer-aided classification of active inflammatory sacroiliitis in magnetic resonance imaging.
Journal: Advances in rheumatology (London, England)
Published: September 10, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026